100 related articles for article (PubMed ID: 1430260)
1. Nasopharyngeal carcinoma in situ in nasopharyngeal carcinoma.
Chan CW; Nicholls JM; Sham JS; Dickens P; Choy D
J Clin Pathol; 1992 Oct; 45(10):898-901. PubMed ID: 1430260
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ.
Yeung WM; Zong YS; Chiu CT; Chan KH; Sham JS; Choy DT; Ng MH
Int J Cancer; 1993 Mar; 53(5):746-50. PubMed ID: 8383629
[TBL] [Abstract][Full Text] [Related]
3. Histopathological types of nasopharyngeal carcinoma in a low-risk area: Japan.
Sugano H; Sakamoto G; Sawaki S; Hirayama T
IARC Sci Publ (1971); 1978; (20):27-39. PubMed ID: 215515
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
Tsai ST; Jin YT; Mann RB; Ambinder RF
Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus DNA in nasopharyngeal carcinomas from Chinese patients in Hong Kong.
Dickens P; Srivastava G; Loke SL; Chan CW; Liu YT
J Clin Pathol; 1992 May; 45(5):396-7. PubMed ID: 1317885
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of CDK5 infers poor outcomes for nasopharyngeal carcinoma patients.
Zhang X; Zhong T; Dang Y; Li Z; Li P; Chen G
Int J Clin Exp Pathol; 2015; 8(7):8066-74. PubMed ID: 26339373
[TBL] [Abstract][Full Text] [Related]
8. The significance of keratinizing squamous cell histology in Chinese patients with nasopharyngeal carcinoma.
Chan AT; Teo ML; Lee WY; Kwan WH; Choi PH; Johnson PJ
Clin Oncol (R Coll Radiol); 1998; 10(3):161-4. PubMed ID: 9704177
[TBL] [Abstract][Full Text] [Related]
9. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
[TBL] [Abstract][Full Text] [Related]
10. The use of brush cytology and directed biopsies for the detection of nasopharyngeal carcinoma and precursor lesions.
Chang AR; Liang XM; Chan AT; Chan MK; Teo PM; Johnson PJ
Head Neck; 2001 Aug; 23(8):637-45. PubMed ID: 11443746
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
Niemhom S; Maeda S; Raksakait K; Petchclai B
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
[TBL] [Abstract][Full Text] [Related]
12. Histopathological classification of nasopharyngeal carcinoma.
Wei KR; Xu Y; Liu J; Zhang WJ; Liang ZH
Asian Pac J Cancer Prev; 2011; 12(5):1141-7. PubMed ID: 21875256
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin.
Watanabe A; Taniguchi M; Tsujie H; Hosokawa M; Fujita M; Sasaki S
Auris Nasus Larynx; 2012 Apr; 39(2):193-7. PubMed ID: 21885222
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma.
Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H
Med Microbiol Immunol; 2003 Aug; 192(3):141-4. PubMed ID: 12920589
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of cytological diagnosis of nasopharyngeal malignancies.
Molinari R; Pilotti S; Rilke F
IARC Sci Publ (1971); 1978; (20):553-63. PubMed ID: 730201
[TBL] [Abstract][Full Text] [Related]
16. B-cell antigen marker expression in nasopharyngeal carcinoma.
Zhong XY; Senba M; Gu JN; Itakura H
Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of histological typing in nasopharyngeal carcinoma.
Cheung F; Chan O; Ng WT; Chan L; Lee A; Pang SW
Oral Oncol; 2012 May; 48(5):429-33. PubMed ID: 22177891
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.
Chao TY; Chow KC; Chang JY; Wang CC; Tsao TY; Harn HJ; Chi KH
Cancer; 1996 Jul; 78(1):24-9. PubMed ID: 8646721
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications.
Tan KB; Putti TC
J Clin Pathol; 2005 May; 58(5):535-8. PubMed ID: 15858127
[TBL] [Abstract][Full Text] [Related]
20. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma.
Codd JD; Salisbury JR; Packham G; Nicholson LJ
J Pathol; 1999 Apr; 187(5):549-55. PubMed ID: 10398120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
